New Option in Pharmacological Treatment of Uterine Fibroids: Selective Progesterone Receptor Modulators
نویسندگان
چکیده
The most frequently identified benign tumor in women is represented by the uterine fibroids with various symptoms: metrorrhagia, dysmenorrhea, anemia, pelvic pain. Nowadays because none of the approved medical treatments has proven able to completely eliminate uterine fibroids, surgery represents the main treatment strategy. Due to its contribution in the growth of leiomyomas, progesterone plays an important role. The purpose of this study is to review the data available regarding the safety and effectiveness of the selective progesterone receptor modulators (SPRM) used in uterine fibroids treatment. A review of the literature was performed between September 2015January 2016 aiming to identify the studies mentioning the use and effectiveness of SPRM in uterine fibroids treatment. A total of 37 studies were identified, 9 matching inclusion criteria. All studies included in our research gave information regarding drug safety, potential benefits, metrorrhagia control and mass reduction of the fibroid. The results were that the pain and life quality showed marked improvement even after therapy interruption. Among all SPRM available (UPAulipristal acetate, asoprinisil, telapristone acetate and GnRh agonists), the treatment with UPA revealed a fast metrorrhagia control and a reduction in the mass dimension, both effects persist even after cessation of medication.
منابع مشابه
Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies
INTRODUCTION The progesterone receptor plays an essential role in uterine physiology and reproduction. Selective progesterone receptor modulators (SPRMs) have emerged as a valuable treatment option for hormone dependent conditions like uterine fibroids, which have a major impact on women's quality of life. SPRMs offer potential for longer term medical treatment and thereby patients may avoid su...
متن کاملThe Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma
Leiomyomas, also known as uterine fibroids, are a common benign tumor in women of reproductive age. These lesions disrupt the function of the uterus causing menorrhagia and pelvic pressure as well as reproductive disorders. These women pose a true challenge for clinicians in the attempt of choosing the suitable treatment for each patient. Patient's age, interest in fertility preservation, and l...
متن کاملUterine fibroids: current perspectives
Uterine fibroids are a major cause of morbidity in women of a reproductive age (and sometimes even after menopause). There are several factors that are attributed to underlie the development and incidence of these common tumors, but this further corroborates their relatively unknown etiology. The most likely presentation of fibroids is by their effect on the woman's menstrual cycle or pelvic pr...
متن کاملUlipristal acetate as a treatment option for uterine fibroids
Uterine fibroids are the most common benign uterine tumours. Clinical symptoms include abnormal bleeding, pelvic pressure, pelvic pain, infertility and obstetric complications. Approximately one third of women with fibroids will require treatment. The management also depends on the number, size, and location of the fibroids. There are surgical and non-surgical treatment options. The choice of t...
متن کاملUterine Fibroids: Diagnosis and Treatment.
Uterine fibroids are common benign neoplasms, with a higher prevalence in older women and in those of African descent. Many are discovered incidentally on clinical examination or imaging in asymptomatic women. Fibroids can cause abnormal uterine bleeding, pelvic pressure, bowel dysfunction, urinary frequency and urgency, urinary retention, low back pain, constipation, and dyspareunia. Ultrasono...
متن کامل